Promise and Peril of Pretomanid-Rifamycin Regimens for Drug-Susceptible Tuberculosis. Velasquez GE, Nahid P. Am J Respir Crit Care Med 2023 Jan 11. doi: 10.1164/rccm.202212-2262.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Velasquez GE, Nahid P. Promise and Peril of Pretomanid-Rifamycin Regimens for Drug-Susceptible Tuberculosis. Am J Respir Crit Care Med 2023 Jan 11. doi: 10.1164/rccm.202212-2262.
PMID: 36630555